NCT04210141View on ClinicalTrials.gov

Optimal Dose of Antivenom for Daboia Siamensis Envenomings

PHASE2SuspendedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

November 1, 2027

Conditions
Daboia Siamensis Envenoming
Interventions
BIOLOGICAL

lyophilized BPI viper antivenom

Antivenom

Trial Locations (1)

Unknown

Myanmar Oxford Clinical Research Unit, Yangon

Sponsors
All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

Myanmar Oxford Clinical Research Unit

OTHER

NCT04210141 - Optimal Dose of Antivenom for Daboia Siamensis Envenomings | Biotech Hunter | Biotech Hunter